Comparison

PCAF-IN-2 European Partner

Item no. HY-147895-25mg
Manufacturer MedChem Express
CASRN 56173-05-8
Amount 25 mg
Category
Type Inhibitor
Specific against other
Purity 98.0
Formula C10H7F3N6
Citations [1]Turky A, et al. Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects. Bioorg Chem. 2020 Aug;101:104019.
Smiles FC(C1=NN=C2N1N=C(NN)C3=C2C=CC=C3)(F)F
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phase[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
268.20
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 8.33 mg/mL (ultrasonic; warming; heat to 80°C)
Manufacturers Target
Apoptosis; Histone Acetyltransferase
Isoform
GCN5/PCAF
Pathway
Apoptosis; Epigenetics
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close